| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale
|
Andrade, Jason G.
|
|
2018
|
206 |
C |
p. 94-104
|
artikel
|
| 2 |
Countering clinical inertia in lipid management: Expert workshop summary
|
Zullig, Leah L.
|
|
2018
|
206 |
C |
p. 24-29
|
artikel
|
| 3 |
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)
|
Cannon, Christopher P.
|
|
2018
|
206 |
C |
p. 11-23
|
artikel
|
| 4 |
Editorial Board
|
|
|
2018
|
206 |
C |
p. iii
|
artikel
|
| 5 |
Information for Readers
|
|
|
2018
|
206 |
C |
p. iv
|
artikel
|
| 6 |
Long-term mortality and estimated functional capacity among women with symptoms of ischemic heart disease: From the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
|
Elgendy, Islam Y.
|
|
2018
|
206 |
C |
p. 123-126
|
artikel
|
| 7 |
Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data Registry
|
Fordyce, Christopher B.
|
|
2018
|
206 |
C |
p. 131-133
|
artikel
|
| 8 |
Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis
|
Lee, Juhwan
|
|
2018
|
206 |
C |
p. 127-130
|
artikel
|
| 9 |
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
|
Pradhan, Aruna D.
|
|
2018
|
206 |
C |
p. 80-93
|
artikel
|
| 10 |
Recovery of failing hearts by mechanical unloading: Pathophysiologic insights and clinical relevance
|
Dandel, Michael
|
|
2018
|
206 |
C |
p. 30-50
|
artikel
|
| 11 |
Risk stratification and clinical outcomes after surgical pulmonary valve replacement
|
Egbe, Alexander C.
|
|
2018
|
206 |
C |
p. 105-112
|
artikel
|
| 12 |
Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease
|
Pagidipati, Neha J.
|
|
2018
|
206 |
C |
p. 51-60
|
artikel
|
| 13 |
Table of Contents
|
|
|
2018
|
206 |
C |
p. i-ii
|
artikel
|
| 14 |
The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts
|
Harrison, Robert W.
|
|
2018
|
206 |
C |
p. 61-71
|
artikel
|
| 15 |
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct
|
Joseph, Philip
|
|
2018
|
206 |
C |
p. 72-79
|
artikel
|
| 16 |
The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians
|
Schulman, Kevin A.
|
|
2018
|
206 |
C |
p. 113-122
|
artikel
|
| 17 |
Thirty-day outcomes in patients with acute pulmonary embolism who discontinued anticoagulant therapy before 90 days
|
Nieto, José A.
|
|
2018
|
206 |
C |
p. 1-10
|
artikel
|
Tijdschrift beschrijving